Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal.

PubWeight™: 1.28‹?› | Rank: Top 10%

🔗 View Article (PMID 2247222)

Published in Neuroscience on January 01, 1990

Authors

L Stinus1, M Le Moal, G F Koob

Author Affiliations

1: Psychobiologies des Comportements Adaptatifs, INSERM, Unité 259, Bordeaux, France.

Articles citing this

Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology (2008) 2.80

Reward processing by the opioid system in the brain. Physiol Rev (2009) 2.46

Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology (2008) 2.16

Brain stress systems in the amygdala and addiction. Brain Res (2009) 2.14

Addiction as a stress surfeit disorder. Neuropharmacology (2013) 1.68

Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev (2010) 1.61

Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug reward memory. J Neurosci (2011) 1.40

Addiction is a Reward Deficit and Stress Surfeit Disorder. Front Psychiatry (2013) 1.39

Accumbens dopamine-acetylcholine balance in approach and avoidance. Curr Opin Pharmacol (2007) 1.35

Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Psychopharmacology (Berl) (2003) 1.15

Neurobiology of dysregulated motivational systems in drug addiction. Future Neurol (2010) 1.14

How to design an opioid drug that causes reduced tolerance and dependence. Ann Neurol (2010) 1.09

Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology (2004) 1.09

Opioid-Induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area. J Neurosci (2010) 1.08

Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol Psychiatry (2008) 1.07

Mechanisms of withdrawal-associated increases in heroin self-administration: pharmacologic modulation of heroin vs food choice in heroin-dependent rhesus monkeys. Neuropsychopharmacology (2008) 1.06

The dark side of emotion: the addiction perspective. Eur J Pharmacol (2015) 1.03

Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Psychopharmacology (Berl) (2003) 1.03

Narp regulates long-term aversive effects of morphine withdrawal. Behav Neurosci (2008) 0.98

Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent mice. Exp Neurol (2008) 0.98

The α3β4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse. Neuropharmacology (2013) 0.97

Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. Br J Pharmacol (1996) 0.96

Withdrawal from acute morphine dependence is accompanied by increased anxiety-like behavior in the elevated plus maze. Pharmacol Biochem Behav (2008) 0.95

Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal. Psychopharmacology (Berl) (2005) 0.93

micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal. J Neurosci (2010) 0.92

An anatomical basis for opponent process mechanisms of opiate withdrawal. J Neurosci (2011) 0.89

Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism. Psychopharmacology (Berl) (2007) 0.88

The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats. Neuropsychopharmacology (2010) 0.87

Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal. PLoS One (2012) 0.87

Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal. Neuropsychopharmacology (2012) 0.87

It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system. Front Pharmacol (2014) 0.86

Ultrastructural relationship between N-methyl-D-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala. Neuroscience (2009) 0.84

Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats. Psychopharmacology (Berl) (2009) 0.84

Low expression of D2R and Wntless correlates with high motivation for heroin. Behav Neurosci (2015) 0.83

Rapid neuroadaptation in the nucleus accumbens and bed nucleus of the stria terminalis mediates suppression of operant responding during withdrawal from acute opioid dependence. Neuroscience (2006) 0.83

Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.83

Expression pattern of neural synaptic plasticity marker-Arc in different brain regions induced by conditioned drug withdrawal from acute morphine-dependent rats. Acta Pharmacol Sin (2009) 0.83

Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure. Psychopharmacology (Berl) (2004) 0.83

Long-term changes in reward-seeking following morphine withdrawal are associated with altered N-methyl-D-aspartate receptor 1 splice variants in the amygdala. Neuroscience (2012) 0.82

Chronic wheel running-induced reduction of extinction and reinstatement of methamphetamine seeking in methamphetamine dependent rats is associated with reduced number of periaqueductal gray dopamine neurons. Brain Struct Funct (2014) 0.82

The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence. Vitam Horm (2010) 0.81

Neurobiology of aversive states. Physiol Behav (2011) 0.80

Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction. Psychopharmacology (Berl) (2017) 0.80

2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice. Psychopharmacology (Berl) (2005) 0.79

CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats. Psychopharmacology (Berl) (2014) 0.79

Pentylenetetrazol produces a state-dependent conditioned place aversion to alcohol withdrawal in mice. Pharmacol Biochem Behav (2010) 0.79

Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice. Drug Alcohol Depend (2014) 0.78

Mediating the effects of drug abuse: the role of Narp in synaptic plasticity. ILAR J (2011) 0.77

GHB ameliorates naloxone-induced conditioned place aversion and physical aspects of morphine withdrawal in mice. Psychopharmacology (Berl) (2004) 0.76

IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats. Gene Ther (2017) 0.75

Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor. Br J Pharmacol (1995) 0.75

Memories of Opiate Withdrawal Emotional States Correlate with Specific Gamma Oscillations in the Nucleus Accumbens. Neuropsychopharmacology (2016) 0.75

Effect of Pharmacological Modulation of the Endocannabinoid System on Opiate Withdrawal: A Review of the Preclinical Animal Literature. Front Pharmacol (2016) 0.75

Effect of Nimodipine on Morphine-related Withdrawal Syndrome in Rat Model: An Observational Study. J Pediatr Neurosci (2017) 0.75

Articles by these authors

Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology (2001) 9.25

Drug abuse: hedonic homeostatic dysregulation. Science (1997) 8.22

Transition from moderate to excessive drug intake: change in hedonic set point. Science (1998) 5.66

Factors that predict individual vulnerability to amphetamine self-administration. Science (1989) 4.10

Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science (1993) 3.67

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res (2000) 3.33

Dramatic decreases in brain reward function during nicotine withdrawal. Nature (1998) 3.21

Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology (2000) 3.15

Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci U S A (2000) 3.15

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron (1998) 3.08

Suppression of psychoactive effects of cocaine by active immunization. Nature (1995) 3.05

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet (2000) 3.04

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology (1998) 2.96

Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend (1998) 2.94

Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther (1993) 2.79

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci (1995) 2.70

Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res (1998) 2.60

Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res (1996) 2.51

Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science (1997) 2.50

Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology (1991) 2.41

The role of stress in drug self-administration. Trends Pharmacol Sci (1998) 2.36

Animal models of drug craving. Psychopharmacology (Berl) (1993) 2.32

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res (1993) 2.27

Cocaine vaccines: antibody protection against relapse in a rat model. Proc Natl Acad Sci U S A (2000) 2.16

Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) (1984) 2.13

Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J Neurosci (2000) 2.12

Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell (1994) 2.05

Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology (2000) 2.04

CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) (1991) 2.04

Long-lasting increase in the set point for cocaine self-administration after escalation in rats. Psychopharmacology (Berl) (1999) 2.01

Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. J Neurosci (1997) 2.01

Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci U S A (1995) 2.00

Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Physiol Behav (1992) 1.96

Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci (1996) 1.95

GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur J Pharmacol (1995) 1.93

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (1996) 1.91

Corticotropin releasing factor produces behavioural activation in rats. Nature (1982) 1.82

A second-generation vaccine protects against the psychoactive effects of cocaine. Proc Natl Acad Sci U S A (2001) 1.78

Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci (2001) 1.78

Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci U S A (1991) 1.76

Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome. Hum Mol Genet (2000) 1.76

Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Psychopharmacology (Berl) (1982) 1.76

Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. J Neuroendocrinol (1994) 1.71

A two-trial memory task with automated recording: study in young and aged rats. Brain Res (1992) 1.68

mu-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther (2000) 1.67

Performance norms for a rhesus monkey neuropsychological testing battery: acquisition and long-term performance. Brain Res Cogn Brain Res (1999) 1.66

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci (1994) 1.65

Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J Neurosci (1996) 1.63

Differential effects of learning on neurogenesis: learning increases or decreases the number of newly born cells depending on their birth date. Mol Psychiatry (2003) 1.63

Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res Brain Res Rev (1997) 1.61

Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci (1994) 1.61

Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res (1991) 1.61

Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res (1992) 1.60

Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res (1995) 1.59

Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol Biochem Behav (1999) 1.58

Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci (1982) 1.57

Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther (2000) 1.56

Novelty-seeking in rats--biobehavioral characteristics and possible relationship with the sensation-seeking trait in man. Neuropsychobiology (1996) 1.56

Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci U S A (1996) 1.56

Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcus aureus has spread to France and acquired reduced susceptibility to teicoplanin. J Antimicrob Chemother (2002) 1.51

Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology (Berl) (1997) 1.50

Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berl) (1987) 1.49

Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav (1980) 1.48

Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther (1994) 1.47

Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. Science (2000) 1.46

Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) (1999) 1.46

Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J Neurosci (1995) 1.46

Operant self-administration of sweetened versus unsweetened ethanol: effects on blood alcohol levels. Alcohol Clin Exp Res (1999) 1.45

Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem (2000) 1.44

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science (1993) 1.43

Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology (1993) 1.43

Cocaine self-administration increases the incentive motivational properties of the drug in rats. Eur J Neurosci (1999) 1.41

Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav (1982) 1.41

Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc Natl Acad Sci U S A (1993) 1.40

Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology (Berl) (2002) 1.40

Long-term effects of prenatal stress and postnatal handling on age-related glucocorticoid secretion and cognitive performance: a longitudinal study in the rat. Eur J Neurosci (1999) 1.40

The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci (2000) 1.40

Lifelong corticosterone level determines age-related decline in neurogenesis and memory. Neurobiol Aging (2005) 1.39

Effects of amphetamine and cocaine treatment on c-Fos, Jun-B, and Krox-24 expression in rats with intrastriatal dopaminergic grafts. Exp Neurol (1999) 1.39

Corticotropin-releasing factor potentiates acoustic startle in rats: blockade by chlordiazepoxide. Psychopharmacology (Berl) (1986) 1.38

Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology (Berl) (1992) 1.38

Social stress increases the acquisition of cocaine self-administration in male and female rats. Brain Res (1995) 1.36

Drugs of abuse and the brain. Proc Assoc Am Physicians (1999) 1.35

Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action. Brain Res (1992) 1.35

Time-dependent quantifiable withdrawal from ethanol in the rat: effect of method of dependence induction. Alcohol (1996) 1.35

Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther (1994) 1.35

Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. J Neurosci (2001) 1.34

Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur J Neurosci (1998) 1.34

Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev (1989) 1.33

Glucocorticoids and behavioral effects of psychostimulants. II: cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther (1997) 1.33

Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci U S A (1997) 1.29

Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther (1992) 1.29

Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res (2001) 1.29

Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaine-induced facilitation of brain reward function in rats. Ann N Y Acad Sci (2003) 1.28

Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm. Alcohol Clin Exp Res (1997) 1.26

Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol (1994) 1.26

Stress-induced sensitization and glucocorticoids. I. Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion. J Neurosci (1995) 1.26

Prenatal stress alters circadian activity of hypothalamo-pituitary-adrenal axis and hippocampal corticosteroid receptors in adult rats of both gender. J Neurobiol (1999) 1.25